Tigatuzumab (Anti-TNFRSF10B / TRAILR2 / CD262)

Synonyms: CS-1008

Tigatuzumab (Anti-TNFRSF10B / TRAILR2 / CD262) is a humanized IgG1 monoclonal antibody targets death receptor 5 (DR5). It induces cell apoptosis of cancer cells and inhibits tumor growth and can be used for the research of cancer. MW :150 KD.

Tigatuzumab (Anti-TNFRSF10B / TRAILR2 / CD262)

Purity & Quality Control

≥99

Choose Selective CD markers Inhibitors

Biological Activity

Description Tigatuzumab (Anti-TNFRSF10B / TRAILR2 / CD262) is a humanized IgG1 monoclonal antibody targets death receptor 5 (DR5). It induces cell apoptosis of cancer cells and inhibits tumor growth and can be used for the research of cancer. MW :150 KD.

Product Details

CAS No. 918127-53-4
Molecular Weight 150
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac,pH5.0
Storage
(From the date of receipt)
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Tigatuzumab (Anti-TNFRSF10B / TRAILR2 / CD262) | Tigatuzumab (Anti-TNFRSF10B / TRAILR2 / CD262) supplier | purchase Tigatuzumab (Anti-TNFRSF10B / TRAILR2 / CD262) | Tigatuzumab (Anti-TNFRSF10B / TRAILR2 / CD262) cost | Tigatuzumab (Anti-TNFRSF10B / TRAILR2 / CD262) manufacturer | order Tigatuzumab (Anti-TNFRSF10B / TRAILR2 / CD262) | Tigatuzumab (Anti-TNFRSF10B / TRAILR2 / CD262) distributor